Sarca Anamaria D, Sardo Luca, Fukuda Hirofumi, Matsui Hiroyuki, Shirakawa Kotaro, Horikawa Kazuki, Takaori-Kondo Akifumi, Izumi Taisuke
Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Department of Biological Sciences, University of the Sciences, Philadelphia, PA, United States.
Front Microbiol. 2021 Mar 9;12:647452. doi: 10.3389/fmicb.2021.647452. eCollection 2021.
HIV-1 infectivity is achieved through virion maturation. Virus particles undergo structural changes via cleavage of the Gag polyprotein mediated by the viral protease, causing the transition from an uninfectious to an infectious status. The majority of proviruses in people living with HIV-1 treated with combination antiretroviral therapy are defective with large internal deletions. Defective proviral DNA frequently preserves intact sequences capable of expressing viral structural proteins to form virus-like particles whose maturation status is an important factor for chronic antigen-mediated immune stimulation and inflammation. Thus, novel methods to study the maturation capability of defective virus particles are needed to characterize their immunogenicity. To build a quantitative tool to study virion maturation , we developed a novel single virion visualization technique based on fluorescence resonance energy transfer (FRET). We inserted an optimized intramolecular CFP-YPF FRET donor-acceptor pair bridged with an HIV-1 protease cleavage sequence between the Gag MA-CA domains. This system allowed us to microscopically distinguish mature and immature virions via their FRET signal when the FRET donor and acceptor proteins were separated by the viral protease during maturation. We found that approximately 80% of the FRET labeled virus particles were mature with equivalent infectivity to wild type. The proportion of immature virions was increased by treatment of virus producer cells with a protease inhibitor in a dose-dependent manner, which corresponded to a relative decrease in infectivity. Potential areas of application for this tool are assessing maturation efficiency in different cell type settings of intact or deficient proviral DNA integrated cells. We believe that this FRET-based single-virion imaging platform will facilitate estimating the impact on the immune system of both extracellular intact and defective viruses by quantifying the Gag maturation status.
HIV-1的感染性通过病毒体成熟来实现。病毒颗粒通过病毒蛋白酶介导的Gag多蛋白裂解而发生结构变化,从而导致从不具感染性状态转变为具感染性状态。接受联合抗逆转录病毒疗法治疗的HIV-1感染者体内的大多数前病毒存在大的内部缺失而有缺陷。有缺陷的前病毒DNA常常保留能够表达病毒结构蛋白以形成病毒样颗粒的完整序列,其成熟状态是慢性抗原介导的免疫刺激和炎症的一个重要因素。因此,需要新的方法来研究有缺陷病毒颗粒的成熟能力,以表征其免疫原性。为构建一种研究病毒体成熟的定量工具,我们基于荧光共振能量转移(FRET)开发了一种新型的单病毒体可视化技术。我们在Gag的MA-CA结构域之间插入了一个优化的分子内CFP-YPF FRET供体-受体对,该对由HIV-1蛋白酶裂解序列连接。当在成熟过程中FRET供体和受体蛋白被病毒蛋白酶分开时,该系统使我们能够通过FRET信号在显微镜下区分成熟和未成熟的病毒体。我们发现,大约80%的FRET标记病毒颗粒是成熟的,其感染性与野生型相当。用蛋白酶抑制剂处理病毒生产细胞会以剂量依赖的方式增加未成熟病毒体的比例,这与感染性的相对降低相对应。该工具的潜在应用领域是评估整合有完整或缺陷前病毒DNA的细胞在不同细胞类型环境中的成熟效率。我们相信,这个基于FRET的单病毒体成像平台将通过量化Gag成熟状态来促进评估细胞外完整和有缺陷病毒对免疫系统的影响。